Randomized placebo-controlled trial of losartan for pediatric NAFLD.

Miriam B VosMark L Van NattaNiviann M BlondetSrinivasan DasarathyMark FishbeinPaula HertelAjay K JainSaul J KarpenJoel E LavineSaeed MohammedLaura A MirielJean P MollestonMarialena MouzakiArun SanyalEmily P SharkeyJeffrey B SchwimmerJames TonasciaLaura A WilsonStavra A Xanthakosnull null

Published in: Hepatology (Baltimore, Md.) (2022)

Losartan did not significantly reduce ALT in children with NAFLD when compared with placebo.

Keyphrases

double blind
placebo controlled
angiotensin ii
clinical trial
phase iii
young adults
phase ii
study protocol
open label
randomized controlled trial